[
  {
    "protocol_id": "user_rTxRY4p1T5YKJ2fAyd587wB5igi1_0_prevention",
    "title": "Prevention Protocol from test_folder/covid19riskandfactors.pdf",
    "steps": [
      {
        "step": 1,
        "text": "Stay current with COVID-19 vaccinations.",
        "explanation": "Keeping up-to-date with COVID-19 vaccines is crucial, especially for older adults and individuals with underlying health conditions, as it significantly reduces the risk of severe illness.",
        "citation": 1
      },
      {
        "step": 2,
        "text": "Adhere to general preventive measures.",
        "explanation": "Following standard preventive measures, such as masking and social distancing, is important, particularly if you are older or have underlying health conditions, to minimize the risk of contracting COVID-19.",
        "citation": 1
      }
    ],
    "citations": [
      {
        "id": 1,
        "source": "test_folder/covid19riskandfactors.pdf",
        "excerpt": "People with Certain Medical Conditions and COVID-19 Risk Factors\nFor Everyone\nJune 11, 2025\nEspañol\nWhat to know\n• If you have any medical conditions listed below, you are more likely to get very sick\nwith COVID-19.\n• This list does not include all conditions.\n• If you have symptoms consistent with ...",
        "organization": "User Upload",
        "year": "2025",
        "region": "User Defined"
      }
    ],
    "source_type": "user",
    "user_id": "rTxRY4p1T5YKJ2fAyd587wB5igi1",
    "created_at": "2025-10-09T22:23:11.872354",
    "region": "User Defined",
    "organization": "Custom Protocol",
    "intent": "prevention"
  },
  {
    "protocol_id": "user_rTxRY4p1T5YKJ2fAyd587wB5igi1_1_treatment",
    "title": "Treatment Protocol from test_folder/covid19riskandfactors.pdf",
    "steps": [
      {
        "step": 1,
        "text": "Start treatment within 5-7 days of symptom onset.",
        "explanation": "Initiating treatment early, within 5 to 7 days from when symptoms begin, is crucial to maximize its effectiveness in reducing the risk of hospitalization and death associated with COVID-19.",
        "citation": 1
      },
      {
        "step": 2,
        "text": "Consider visiting a Test to Treat location.",
        "explanation": "Test to Treat locations offer convenient access to testing and immediate treatment if you test positive for COVID-19, streamlining the process of getting timely care.",
        "citation": 1
      }
    ],
    "citations": [
      {
        "id": 1,
        "source": "test_folder/covid19riskandfactors.pdf",
        "excerpt": "e with\ndisabilities.\nSpecific information on children and teens\nPeople of all ages, including children and teens, can get very sick from COVID-19,\nespecially those with underlying medical conditions. This includes children and teens with:\n• Medical complexity\n• Genetic, neurologic, or metabolic cond...",
        "organization": "User Upload",
        "year": "2025",
        "region": "User Defined"
      }
    ],
    "source_type": "user",
    "user_id": "rTxRY4p1T5YKJ2fAyd587wB5igi1",
    "created_at": "2025-10-09T22:23:13.899770",
    "region": "User Defined",
    "organization": "Custom Protocol",
    "intent": "treatment"
  },
  {
    "protocol_id": "user_rTxRY4p1T5YKJ2fAyd587wB5igi1_2_prevention",
    "title": "Prevention Protocol from test_folder/covid19riskandfactors.pdf",
    "steps": [
      {
        "step": 1,
        "text": "Vaccinate children and teens against COVID-19",
        "explanation": "Parents of children aged 6 months to 17 years should consult with a healthcare provider about the benefits of COVID-19 vaccination to protect them from severe illness. Vaccination is especially important for those with underlying medical conditions.",
        "citation": 1
      },
      {
        "step": 2,
        "text": "Consult healthcare provider about specific medical conditions",
        "explanation": "If you have questions about managing a medical condition or protecting yourself from COVID-19, consult your healthcare provider for personalized advice and treatment options. This is especially important for conditions not explicitly listed.",
        "citation": 1
      }
    ],
    "citations": [
      {
        "id": 1,
        "source": "test_folder/covid19riskandfactors.pdf",
        "excerpt": "e with\ndisabilities.\nSpecific information on children and teens\nPeople of all ages, including children and teens, can get very sick from COVID-19,\nespecially those with underlying medical conditions. This includes children and teens with:\n• Medical complexity\n• Genetic, neurologic, or metabolic cond...",
        "organization": "User Upload",
        "year": "2025",
        "region": "User Defined"
      }
    ],
    "source_type": "user",
    "user_id": "rTxRY4p1T5YKJ2fAyd587wB5igi1",
    "created_at": "2025-10-09T22:23:15.839753",
    "region": "User Defined",
    "organization": "Custom Protocol",
    "intent": "prevention"
  },
  {
    "protocol_id": "user_rTxRY4p1T5YKJ2fAyd587wB5igi1_3_treatment",
    "title": "Treatment Protocol from test_folder/covid19riskandfactors.pdf",
    "steps": [
      {
        "step": 1,
        "text": "Consider Pemivibart (Pemgarda™) for immunocompromised patients (12+ years, ≥88 pounds).",
        "explanation": "Pemivibart, a monoclonal antibody, can offer extra protection against COVID-19 for moderately to severely immunocompromised individuals aged 12 and older, weighing at least 88 pounds. It can be administered at least 2 weeks post-vaccination.",
        "citation": 1
      },
      {
        "step": 2,
        "text": "Consult healthcare provider about additional precautions for immunocompromised individuals.",
        "explanation": "Patients with compromised immune systems, even if vaccinated, may need extra precautions. Discuss specific risks and necessary actions with their healthcare provider to ensure adequate protection.",
        "citation": 1
      },
      {
        "step": 3,
        "text": "Assess eligibility for additional COVID-19 vaccine doses in immunocompromised patients.",
        "explanation": "Moderately or severely immunocompromised individuals may benefit from extra doses of the updated COVID-19 vaccine. Specific guidance has been developed due to potentially differing immune responses post-vaccination.",
        "citation": 1
      }
    ],
    "citations": [
      {
        "id": 1,
        "source": "test_folder/covid19riskandfactors.pdf",
        "excerpt": "omised condition or weakened immune system\nPeople who are immunocompromised or are taking medicines that weaken their immune\nsystem may not be protected even if they are up to date on their vaccines. Examples\ninclude:\n• People who have cancer and are on chemotherapy\n• People who have had a solid org...",
        "organization": "User Upload",
        "year": "2025",
        "region": "User Defined"
      }
    ],
    "source_type": "user",
    "user_id": "rTxRY4p1T5YKJ2fAyd587wB5igi1",
    "created_at": "2025-10-09T22:23:23.046467",
    "region": "User Defined",
    "organization": "Custom Protocol",
    "intent": "treatment"
  },
  {
    "protocol_id": "user_rTxRY4p1T5YKJ2fAyd587wB5igi1_4_prevention",
    "title": "Prevention Protocol from test_folder/covid19riskandfactors.pdf",
    "steps": [
      {
        "step": 1,
        "text": "Consult healthcare provider about additional precautions.",
        "explanation": "Immunocompromised individuals, including those with cancer (on chemotherapy), transplant recipients (on immunosuppressants), or those on long-term corticosteroids, should discuss additional protective measures with their healthcare provider, as vaccines may not provide sufficient protection.",
        "citation": 1
      },
      {
        "step": 2,
        "text": "Consider additional COVID-19 vaccine doses.",
        "explanation": "Moderately or severely immunocompromised individuals may benefit from extra doses of the updated COVID-19 vaccine due to potentially different immune responses following vaccination. Consult with a healthcare provider for specific guidance.",
        "citation": 1
      },
      {
        "step": 3,
        "text": "Evaluate eligibility for Pemivibart (Pemgarda™).",
        "explanation": "Individuals 12 years and older, weighing at least 88 pounds, and who are moderately or severely immunocompromised may be eligible for Pemivibart, a monoclonal antibody, to help protect against COVID-19, providing an additional layer of protection alongside vaccination.",
        "citation": 1
      },
      {
        "step": 4,
        "text": "Administer Pemgarda at least 2 weeks after COVID-19 vaccination.",
        "explanation": "If deemed eligible, Pemgarda should be given at least two weeks after the individual has received a COVID-19 vaccine to maximize its protective effect. Note that Pemgarda is not a treatment for COVID-19.",
        "citation": 1
      }
    ],
    "citations": [
      {
        "id": 1,
        "source": "test_folder/covid19riskandfactors.pdf",
        "excerpt": "omised condition or weakened immune system\nPeople who are immunocompromised or are taking medicines that weaken their immune\nsystem may not be protected even if they are up to date on their vaccines. Examples\ninclude:\n• People who have cancer and are on chemotherapy\n• People who have had a solid org...",
        "organization": "User Upload",
        "year": "2025",
        "region": "User Defined"
      }
    ],
    "source_type": "user",
    "user_id": "rTxRY4p1T5YKJ2fAyd587wB5igi1",
    "created_at": "2025-10-09T22:23:25.895289",
    "region": "User Defined",
    "organization": "Custom Protocol",
    "intent": "prevention"
  }
]